Literature DB >> 25082799

Targeting adaptive glioblastoma: an overview of proliferation and invasion.

Qian Xie1, Sandeep Mittal1, Michael E Berens1.   

Abstract

Glioblastoma is one of the most devastating cancers, in which tumor cell infiltration into surrounding normal brain tissue confounds clinical management. This review describes basic and translational research into glioma proliferation and invasion, in particular the phenotypic switch underlying a stochastic "go or grow" model of tumor cell behavior. We include recent progress in system genomics, cancer stem cell theory, and tumor-microenvironment interaction, from which novel therapeutic strategies may emerge for managing this malignant disease. We suggest that an effective therapeutic strategy should target both adaptive glioblastoma cells and the stroma-tumor interaction.
© The Author(s) 2014. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  glioblastoma; invasion; proliferation; targeted therapy

Mesh:

Year:  2014        PMID: 25082799      PMCID: PMC4232088          DOI: 10.1093/neuonc/nou147

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  93 in total

1.  AACR special conference on epithelial-mesenchymal transition and cancer progression and treatment.

Authors:  Evanthia T Roussos; Zuzana Keckesova; John D Haley; David M Epstein; Robert A Weinberg; John S Condeelis
Journal:  Cancer Res       Date:  2010-09-07       Impact factor: 12.701

2.  Phenotypic diversity, population growth, and information in fluctuating environments.

Authors:  Edo Kussell; Stanislas Leibler
Journal:  Science       Date:  2005-08-25       Impact factor: 47.728

3.  Angiogenesis inhibition for glioblastoma at the edge: beyond AVAGlio and RTOG 0825.

Authors:  Michael Weller; W K Alfred Yung
Journal:  Neuro Oncol       Date:  2013-08       Impact factor: 12.300

4.  RTK inhibition: looking for the right pathways toward a miracle.

Authors:  Qian Xie; George F Vande Woude; Michael E Berens
Journal:  Future Oncol       Date:  2012-11       Impact factor: 3.404

5.  MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells.

Authors:  Jakub Godlewski; Michal O Nowicki; Agnieszka Bronisz; Gerard Nuovo; Jeff Palatini; Michael De Lay; James Van Brocklyn; Michael C Ostrowski; E Antonio Chiocca; Sean E Lawler
Journal:  Mol Cell       Date:  2010-03-12       Impact factor: 17.970

6.  High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene.

Authors:  Alejandra Bruna; Rachel S Darken; Federico Rojo; Alberto Ocaña; Silvia Peñuelas; Alexandra Arias; Raquel Paris; Avelina Tortosa; Jaume Mora; Jose Baselga; Joan Seoane
Journal:  Cancer Cell       Date:  2007-02       Impact factor: 31.743

7.  Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC.

Authors:  Alexa B Turke; Kreshnik Zejnullahu; Yi-Long Wu; Youngchul Song; Dora Dias-Santagata; Eugene Lifshits; Luca Toschi; Andrew Rogers; Tony Mok; Lecia Sequist; Neal I Lindeman; Carly Murphy; Sara Akhavanfard; Beow Y Yeap; Yun Xiao; Marzia Capelletti; A John Iafrate; Charles Lee; James G Christensen; Jeffrey A Engelman; Pasi A Jänne
Journal:  Cancer Cell       Date:  2010-01-19       Impact factor: 31.743

8.  Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis.

Authors:  Erik Sahai; Christopher J Marshall
Journal:  Nat Cell Biol       Date:  2003-08       Impact factor: 28.824

Review 9.  Showering c-MET-dependent cancers with drugs.

Authors:  Beatrice S Knudsen; George Vande Woude
Journal:  Curr Opin Genet Dev       Date:  2008-04-09       Impact factor: 5.578

10.  IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas.

Authors:  Takuya Watanabe; Sumihito Nobusawa; Paul Kleihues; Hiroko Ohgaki
Journal:  Am J Pathol       Date:  2009-02-26       Impact factor: 4.307

View more
  107 in total

1.  Myosin IIA suppresses glioblastoma development in a mechanically sensitive manner.

Authors:  Hannah S Picariello; Rajappa S Kenchappa; Vandana Rai; James F Crish; Athanassios Dovas; Katarzyna Pogoda; Mariah McMahon; Emily S Bell; Unnikrishnan Chandrasekharan; Amanda Luu; Rita West; Jan Lammerding; Peter Canoll; David J Odde; Paul A Janmey; Thomas Egelhoff; Steven S Rosenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-24       Impact factor: 11.205

2.  A 3D topographical model of parenchymal infiltration and perivascular invasion in glioblastoma.

Authors:  Kayla J Wolf; Stacey Lee; Sanjay Kumar
Journal:  APL Bioeng       Date:  2018-04-01

3.  Prognostic Molecular and Imaging Biomarkers in Primary Glioblastoma.

Authors:  Edit Bosnyák; Sharon K Michelhaugh; Neil V Klinger; David O Kamson; Geoffrey R Barger; Sandeep Mittal; Csaba Juhász
Journal:  Clin Nucl Med       Date:  2017-05       Impact factor: 7.794

4.  ERBB3, IGF1R, and TGFBR2 expression correlate with PDGFR expression in glioblastoma and participate in PDGFR inhibitor resistance of glioblastoma cells.

Authors:  Kang Song; Ye Yuan; Yong Lin; Yan-Xia Wang; Jie Zhou; Qu-Jing Gai; Lin Zhang; Min Mao; Xiao-Xue Yao; Yan Qin; Hui-Min Lu; Xiang Zhang; You-Hong Cui; Xiu-Wu Bian; Xia Zhang; Yan Wang
Journal:  Am J Cancer Res       Date:  2018-05-01       Impact factor: 6.166

5.  The aryl hydrocarbon receptor is a tumor suppressor-like gene in glioblastoma.

Authors:  Un-Ho Jin; Keshav Karki; Yating Cheng; Sharon K Michelhaugh; Sandeep Mittal; Stephen Safe
Journal:  J Biol Chem       Date:  2019-06-06       Impact factor: 5.157

6.  Tryptophan PET predicts spatial and temporal patterns of post-treatment glioblastoma progression detected by contrast-enhanced MRI.

Authors:  Edit Bosnyák; David O Kamson; Natasha L Robinette; Geoffrey R Barger; Sandeep Mittal; Csaba Juhász
Journal:  J Neurooncol       Date:  2015-10-29       Impact factor: 4.130

7.  EGFRvIII-Stat5 Signaling Enhances Glioblastoma Cell Migration and Survival.

Authors:  Alison Roos; Harshil D Dhruv; Sen Peng; Landon J Inge; Serdar Tuncali; Michael Pineda; Nghia Millard; Zachary Mayo; Jennifer M Eschbacher; Joseph C Loftus; Jeffrey A Winkles; Nhan L Tran
Journal:  Mol Cancer Res       Date:  2018-05-03       Impact factor: 5.852

8.  Residual Tumor Volume, Cell Volume Fraction, and Tumor Cell Kill During Fractionated Chemoradiation Therapy of Human Glioblastoma using Quantitative Sodium MR Imaging.

Authors:  Keith R Thulborn; Aiming Lu; Ian C Atkinson; Mohan Pauliah; Kathryn Beal; Timothy A Chan; Antonio Omuro; Josh Yamada; Michelle S Bradbury
Journal:  Clin Cancer Res       Date:  2018-11-28       Impact factor: 12.531

9.  Zeb1 potentiates genome-wide gene transcription with Lef1 to promote glioblastoma cell invasion.

Authors:  Pedro Rosmaninho; Susanne Mükusch; Valerio Piscopo; Vera Teixeira; Alexandre Asf Raposo; Rolf Warta; Romina Bennewitz; Yeman Tang; Christel Herold-Mende; Stefano Stifani; Stefan Momma; Diogo S Castro
Journal:  EMBO J       Date:  2018-06-14       Impact factor: 11.598

10.  Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth.

Authors:  Yuan Zhu; Kai Zhao; Anja Prinz; Kathy Keyvani; Nicole Lambertz; Ilonka Kreitschmann-Andermahr; Ting Lei; Ulrich Sure
Journal:  Neuro Oncol       Date:  2015-08-08       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.